How much revenue did HGH Holdings generate this year?
HGH Holdings has achieved a revenue of 20.03 M SGD this year.
HGH Holdings Revenue 2025
HGH Holdings Revenue
20.03 M SGD
Ticker
5GZ.SI
ISIN
SG1S12926576
In 2025, HGH Holdings's sales reached 20.03 M SGD, a -7.2% difference from the 21.59 M SGD sales recorded in the previous year.
The HGH Holdings Revenue history
| YEAR | REVENUE (undefined SGD) | GROSS MARGIN (%) |
|---|---|---|
| 2023 | 20.03 | 18,87 |
| 2022 | 21.59 | 17,77 |
| 2021 | 20.07 | 22,69 |
| 2020 | 11.7 | 31,23 |
| 2019 | 23.9 | 37,69 |
| 2018 | 19.59 | 28,13 |
| 2017 | 11.18 | 30,46 |
| 2016 | - | - |
| 2015 | 15.47 | 5,14 |
| 2014 | 15.69 | 8,38 |
| 2013 | 15.99 | 6,00 |
| 2012 | 14.3 | 9,02 |
| 2011 | 14.85 | 5,52 |
| 2010 | 18.26 | 10,90 |
| 2009 | 25.36 | 7,33 |
| 2008 | 17.31 | 5,55 |
| 2007 | 22.17 | 13,71 |
| 2006 | 19.08 | 18,08 |
| 2005 | 19.34 | 24,92 |
| 2004 | 16.25 | 24,55 |
HGH Holdings Revenue, EBIT, Net Income SG1S12926576 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into HGH Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by HGH Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects HGH Holdings’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of HGH Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into HGH Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing HGH Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on HGH Holdings’s growth potential.
HGH Holdings Revenue, EBIT and net profit per share
| Date | HGH Holdings Revenue | HGH Holdings EBIT | HGH Holdings Net Income |
|---|---|---|---|
| 2023 | 20.03 M undefined | -729,930 undefined | -306,970 undefined |
| 2022 | 21.59 M undefined | -2.02 M undefined | -1.5 M undefined |
| 2021 | 20.07 M undefined | -1.99 M undefined | -2.27 M undefined |
| 2020 | 11.7 M undefined | -2.9 M undefined | -4.24 M undefined |
| 2019 | 23.9 M undefined | -39,280 undefined | -5.9 M undefined |
| 2018 | 19.59 M undefined | -919,180 undefined | -5.7 M undefined |
| 2017 | 11.18 M undefined | -823,770 undefined | 29.34 M undefined |
| 2016 | 0 undefined | -1.21 M undefined | -1.22 M undefined |
| 2015 | 15.47 M undefined | 489,140 undefined | -143,010 undefined |
| 2014 | 15.69 M undefined | 170,850 undefined | -9,560 undefined |
| 2013 | 15.99 M undefined | 360,000 undefined | 300,000 undefined |
| 2012 | 14.3 M undefined | 630,000 undefined | 20,000 undefined |
| 2011 | 14.85 M undefined | 110,000 undefined | -470,000 undefined |
| 2010 | 18.26 M undefined | 1.47 M undefined | 200,000 undefined |
| 2009 | 25.36 M undefined | 930,000 undefined | 170,000 undefined |
| 2008 | 17.31 M undefined | 20,000 undefined | -490,000 undefined |
| 2007 | 22.17 M undefined | 2.08 M undefined | 920,000 undefined |
| 2006 | 19.08 M undefined | 2.23 M undefined | 1.28 M undefined |
| 2005 | 19.34 M undefined | 3.51 M undefined | 2.38 M undefined |
| 2004 | 16.25 M undefined | 3.58 M undefined | 2.74 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 16.25 M SGD | 3.58 M SGD | 2.74 M SGD |
| 2005 | 19.34 M SGD | 3.51 M SGD | 2.38 M SGD |
| 2006 | 19.08 M SGD | 2.23 M SGD | 1.28 M SGD |
| 2007 | 22.17 M SGD | 2.08 M SGD | 920,000 SGD |
| 2008 | 17.31 M SGD | 20,000 SGD | -490,000 SGD |
| 2009 | 25.36 M SGD | 930,000 SGD | 170,000 SGD |
| 2010 | 18.26 M SGD | 1.47 M SGD | 200,000 SGD |
| 2011 | 14.85 M SGD | 110,000 SGD | -470,000 SGD |
| 2012 | 14.3 M SGD | 630,000 SGD | 20,000 SGD |
| 2013 | 15.99 M SGD | 360,000 SGD | 300,000 SGD |
| 2014 | 15.69 M SGD | 170,850 SGD | -9,560 SGD |
| 2015 | 15.47 M SGD | 489,140 SGD | -143,010 SGD |
| 2016 | 0 SGD | -1.21 M SGD | -1.22 M SGD |
| 2017 | 11.18 M SGD | -823,770 SGD | 29.34 M SGD |
| 2018 | 19.59 M SGD | -919,180 SGD | -5.7 M SGD |
| 2019 | 23.9 M SGD | -39,280 SGD | -5.9 M SGD |
| 2020 | 11.7 M SGD | -2.9 M SGD | -4.24 M SGD |
| 2021 | 20.07 M SGD | -1.99 M SGD | -2.27 M SGD |
| 2022 | 21.59 M SGD | -2.02 M SGD | -1.5 M SGD |
| 2023 | 20.03 M SGD | -729,930 SGD | -306,970 SGD |
HGH Holdings stock margins SG1S12926576 ·
The HGH Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of HGH Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for HGH Holdings.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the HGH Holdings's sales revenue. A higher gross margin percentage indicates that the HGH Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the HGH Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the HGH Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the HGH Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the HGH Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the HGH Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
HGH Holdings Margin History
| HGH Holdings Gross margin | HGH Holdings Profit margin | HGH Holdings EBIT margin | HGH Holdings Profit margin |
|---|---|---|---|
| 2023 | 18.87 % | -3.64 % | -1.53 % |
| 2022 | 17.77 % | -9.35 % | -6.97 % |
| 2021 | 22.69 % | -9.89 % | -11.32 % |
| 2020 | 31.23 % | -24.79 % | -36.22 % |
| 2019 | 37.69 % | -0.16 % | -24.7 % |
| 2018 | 28.13 % | -4.69 % | -29.11 % |
| 2017 | 30.46 % | -7.36 % | 262.34 % |
| 2016 | 18.87 % | 0 % | 0 % |
| 2015 | 5.14 % | 3.16 % | -0.92 % |
| 2014 | 8.38 % | 1.09 % | -0.06 % |
| 2013 | 6 % | 2.25 % | 1.88 % |
| 2012 | 9.02 % | 4.41 % | 0.14 % |
| 2011 | 5.52 % | 0.74 % | -3.16 % |
| 2010 | 10.9 % | 8.05 % | 1.1 % |
| 2009 | 7.33 % | 3.67 % | 0.67 % |
| 2008 | 5.55 % | 0.12 % | -2.83 % |
| 2007 | 13.71 % | 9.38 % | 4.15 % |
| 2006 | 18.08 % | 11.69 % | 6.71 % |
| 2005 | 24.92 % | 18.15 % | 12.31 % |
| 2004 | 24.55 % | 22.03 % | 16.86 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 24.55 % | 22.03 % | 16.86 % |
| 2005 | 24.92 % | 18.15 % | 12.31 % |
| 2006 | 18.08 % | 11.69 % | 6.71 % |
| 2007 | 13.71 % | 9.38 % | 4.15 % |
| 2008 | 5.55 % | 0.12 % | -2.83 % |
| 2009 | 7.33 % | 3.67 % | 0.67 % |
| 2010 | 10.9 % | 8.05 % | 1.1 % |
| 2011 | 5.52 % | 0.74 % | -3.16 % |
| 2012 | 9.02 % | 4.41 % | 0.14 % |
| 2013 | 6 % | 2.25 % | 1.88 % |
| 2014 | 8.38 % | 1.09 % | -0.06 % |
| 2015 | 5.14 % | 3.16 % | -0.92 % |
| 2016 | 18.87 % | 0 % | 0 % |
| 2017 | 30.46 % | -7.36 % | 262.34 % |
| 2018 | 28.13 % | -4.69 % | -29.11 % |
| 2019 | 37.69 % | -0.16 % | -24.7 % |
| 2020 | 31.23 % | -24.79 % | -36.22 % |
| 2021 | 22.69 % | -9.89 % | -11.32 % |
| 2022 | 17.77 % | -9.35 % | -6.97 % |
| 2023 | 18.87 % | -3.64 % | -1.53 % |
HGH Holdings Aktienanalyse
What does HGH Holdings do?
HGH Holdings Ltd is a leading company specializing in technology-based solutions in the areas of security, surveillance, and industrial inspection. The company was founded in 1982 and is headquartered in the UK. In its early years, HGH specialized in trading hydraulic components. With years of experience, the management recognized the potential of digitization and began investing in the development of technologies for optical monitoring of industrial facilities. Today, HGH offers a wide range of products and services, from software and hardware development for sensors to turnkey construction of surveillance systems for perimeter protection or monitoring of industrial facilities. The company collaborates with customers in various industries, including oil and gas, power supply, aerospace, as well as military and defense. The main divisions of HGH Holdings Ltd include: 1. Division: Infrared cameras and thermal imaging systems Properly used infrared cameras can be employed in various areas to detect excessive heat emissions that could indicate potential issues in facilities. HGH offers a variety of high-tech cameras and systems tailored to the specific needs of customers. These include systems for room surveillance, fire detection, vehicle or personnel monitoring, and monitoring of railway tracks. 2. Division: Security equipment and systems As an increasingly important topic, HGH provides professional security equipment to ensure customers' protection. This includes proven armored vehicles, mobile and stationary barrier systems, as well as intrusion detection and surveillance systems, all contributing to increased security. 3. Division: Remote sensing systems and UAVs HGH Holdings Ltd also offers remote monitoring and exploration systems developed and deployed based on drones or authorized UAVs (Unmanned Aerial Vehicles). These specially equipped drones are capable of collecting data and images to enable quick and effective surveillance and inspection of hard-to-reach locations. In addition to technology development, HGH Holdings Ltd. also provides technical support, training, and a variety of services related to the technological solutions offered by the company. This allows customers to receive tailored solutions that meet their specific requirements. Since its founding, HGH Holdings Ltd. has continuously invested in researching and developing new technologies and products, establishing itself as one of the leading developers in this field. The constant improvement of technology quality and efficiency enables HGH to continue to succeed on both national and international levels, establishing itself as a trusted partner in various industries. HGH Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding HGH Holdings's Sales Figures
The sales figures of HGH Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing HGH Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize HGH Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in HGH Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about HGH Holdings stock
How much was the turnover of the company HGH Holdings compared to the previous year?
The revenue of HGH Holdings has increased by -7.2% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of HGH Holdings?
The revenue of HGH Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of HGH Holdings measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of HGH Holdings so important for investors?
The revenue of HGH Holdings is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does HGH Holdings pay?
Over the past 12 months, HGH Holdings paid a dividend of 0 SGD . This corresponds to a dividend yield of about 11.78 %. For the coming 12 months, HGH Holdings is expected to pay a dividend of 0 SGD.
What is the dividend yield of HGH Holdings?
The current dividend yield of HGH Holdings is 11.78 %.
When does HGH Holdings pay dividends?
HGH Holdings pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of HGH Holdings?
HGH Holdings paid dividends every year for the past 0 years.
What is the dividend of HGH Holdings?
For the upcoming 12 months, dividends amounting to 0 SGD are expected. This corresponds to a dividend yield of 0 %.
In which sector is HGH Holdings located?
HGH Holdings is assigned to the 'Real Estate' sector.
Wann musste ich die Aktien von HGH Holdings kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of HGH Holdings from 5/14/2007 amounting to 0.01 SGD, you needed to have the stock in your portfolio before the ex-date on 4/27/2007.
When did HGH Holdings pay the last dividend?
The last dividend was paid out on 5/14/2007.
What was the dividend of HGH Holdings in the year 2024?
In the year 2024, HGH Holdings distributed 0 SGD as dividends.
In which currency does HGH Holdings pay out the dividend?
The dividends of HGH Holdings are distributed in SGD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von HGH Holdings
Our stock analysis for HGH Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HGH Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- HGH Holdings Revenue
- HGH Holdings Net Income
- HGH Holdings P/E
- HGH Holdings P/S
- HGH Holdings EBIT
- HGH Holdings Dividend
- HGH Holdings Stocks
- HGH Holdings Market capitalization
- HGH Holdings Debt
- HGH Holdings Liabilities
- HGH Holdings Equity
- HGH Holdings AAQS
- HGH Holdings Employees
- HGH Holdings ROE
- HGH Holdings ROA
- HGH Holdings ROCE
